* Viemed Healthcare Inc VMD.TO is expected to report
results on
March 2.
* The Lafayette Louisiana-based company is expected to
report
revenue of $37.75 million, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Viemed Healthcare
Inc is
for earnings of 5 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Viemed
Healthcare
Inc is $13, above its last closing price of $9.21.
This summary was machine generated February 28 at 21:39 GMT.
All figures in US dollars unless otherwise stated